Insider Buy/Sell Ratio for May 2026
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys188
Sells2732
Buy $$203.73M
Sell $$4.82B
Ratio1:23.67
% Change vs. Prior
Ratio -99.1%Value -76.7%
Healthcare
Buys175
Sells1262
Buy $$145.28M
Sell $$2.37B
Ratio1:16.33
% Change vs. Prior
Ratio -39.2%Value +125.5%
Industrials
Buys160
Sells752
Buy $$254.35M
Sell $$1.67B
Ratio1:6.57
% Change vs. Prior
Ratio +2623.4%Value -50.1%
Financial Services
Buys417
Sells917
Buy $$475.37M
Sell $$1.45B
Ratio1:3.05
% Change vs. Prior
Ratio +616.9%Value +68.1%
Energy
Buys84
Sells202
Buy $$39.06M
Sell $$1.24B
Ratio1:31.72
% Change vs. Prior
Ratio -79.2%Value +192.3%
Consumer Cyclical
Buys140
Sells540
Buy $$45.96M
Sell $$1.23B
Ratio1:26.74
% Change vs. Prior
Ratio -98.2%Value -14.2%
Utilities
Buys34
Sells115
Buy $$48.81M
Sell $$673.78M
Ratio1:13.81
% Change vs. Prior
Ratio +619.7%Value +19.2%
Communication Services
Buys45
Sells241
Buy $$12.67M
Sell $$453.57M
Ratio1:35.80
% Change vs. Prior
Ratio +72.0%Value +152.0%
Consumer Defensive
Buys65
Sells200
Buy $$98.74M
Sell $$321.62M
Ratio1:3.26
% Change vs. Prior
Ratio +73.1%Value +241.6%
Basic Materials
Buys55
Sells89
Buy $$10.22M
Sell $$102.02M
Ratio1:9.99
% Change vs. Prior
Ratio +2.8%Value -64.2%
Real Estate
Buys81
Sells67
Buy $$24.38M
Sell $$87.45M
Ratio1:3.59
% Change vs. Prior
Ratio -81.9%Value +30.7%
By Industry
Software - Infrastructure
Buys18
Sells1011
Buy $$24.37M
Sell $$2.09B
Ratio1:85.93
% Change vs. Prior
Ratio +517.9%Value +6.9%
Semiconductors
Buys42
Sells600
Buy $$1.74M
Sell $$1.12B
Ratio1:640.20
% Change vs. Prior
Ratio +48.6%Value +166.6%
Medical - Diagnostics & Research
Buys3
Sells106
Buy $$781.14K
Sell $$858.09M
Ratio1:1098.51
Construction
Buys8
Sells25
Buy $$16.06M
Sell $$774.21M
Ratio1:48.21
Leisure
Buys25
Sells41
Buy $$1.68M
Sell $$740.75M
Ratio1:440.59
Asset Management
Buys84
Sells78
Buy $$11.23M
Sell $$682.10M
Ratio1:60.74
Software - Application
Buys101
Sells359
Buy $$174.60M
Sell $$492.72M
Ratio1:2.82
% Change vs. Prior
Ratio +43.3%Value +182.0%
Renewable Utilities
Buys12
Sells74
Buy $$44.10M
Sell $$587.16M
Ratio1:13.32
% Change vs. Prior
Ratio +83126.7%Value +23.4%
Biotechnology
Buys67
Sells869
Buy $$110.02M
Sell $$435.50M
Ratio1:3.96
% Change vs. Prior
Ratio +225.8%Value -41.4%
Financial - Capital Markets
Buys7
Sells149
Buy $$339.42M
Sell $$195.68M
Ratio1.73:1
Information Technology Services
Buys17
Sells91
Buy $$2.18M
Sell $$522.62M
Ratio1:240.19
Medical - Care Facilities
Buys8
Sells25
Buy $$3.17M
Sell $$489.18M
Ratio1:154.10
Oil & Gas Equipment & Services
Buys2
Sells38
Buy $$450.65K
Sell $$487.59M
Ratio1:1081.96
% Change vs. Prior
Ratio +114.2%Value +237.0%
Oil & Gas Exploration & Production
Buys49
Sells43
Buy $$19.17M
Sell $$466.64M
Ratio1:24.35
Medical - Healthcare Plans
Buys1
Sells32
Buy $$2.70K
Sell $$398.02M
Ratio1:147415.68
Transactions (8678)
FirstCash Holdings, Inc. (FCFS)
ORR R DOUGLAS — EVP & Chief Financial Officer
Shares
1,000
Price
$227.31
Total Value
$227.31K
Shares Held After
41,610
% of Holdings
2.3%
FirstCash Holdings, Inc. (FCFS)
ORR R DOUGLAS — EVP & Chief Financial Officer
Shares
1,000
Price
$227.32
Total Value
$227.32K
Shares Held After
96,789
% of Holdings
1.0%
FirstCash Holdings, Inc. (FCFS)
Stuart Thomas Brent — President and COO
Shares
10,000
Price
$228.49
Total Value
$2.28M
Shares Held After
140,846
% of Holdings
6.6%
Coursera, Inc. (COUR)
Cardenas Alan B — SVP, General Counsel
Shares
9,139
Price
$5.52
Total Value
$50.45K
Shares Held After
255,934
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$570.18
Total Value
$22.81K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,322
Price
$569.56
Total Value
$752.96K
Shares Held After
18,916
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,304
Price
$568.43
Total Value
$741.23K
Shares Held After
20,238
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,785
Price
$568.48
Total Value
$1.58M
Shares Held After
21,542
% of Holdings
11.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,796
Price
$566.39
Total Value
$1.02M
Shares Held After
24,327
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,131
Price
$565.44
Total Value
$1.20M
Shares Held After
26,123
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
422
Price
$564.30
Total Value
$238.14K
Shares Held After
28,254
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$562.91
Total Value
$112.58K
Shares Held After
28,676
% of Holdings
0.7%
VTEX (NYSE: VTEX)
Gomes Andre Spolidoro Ferreira — Chief Strategy Officer
Shares
1,500
Price
$3.51
Total Value
$5.26K
Shares Held After
42,400
% of Holdings
3.4%
VTEX (NYSE: VTEX)
Gomes Andre Spolidoro Ferreira — Chief Strategy Officer
Shares
1,500
Price
$3.51
Total Value
$5.26K
Shares Held After
312,029
% of Holdings
0.5%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
3,195
Price
$65.95
Total Value
$210.71K
Shares Held After
359,194
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
10,456
Price
$64.82
Total Value
$677.71K
Shares Held After
362,389
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$569.99
Total Value
$159.60K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$569.42
Total Value
$613.26K
Shares Held After
40,793
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,437
Price
$568.33
Total Value
$816.69K
Shares Held After
41,870
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,280
Price
$567.45
Total Value
$1.29M
Shares Held After
43,307
% of Holdings
5.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,117
Price
$566.33
Total Value
$1.20M
Shares Held After
45,587
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,811
Price
$565.34
Total Value
$1.02M
Shares Held After
47,704
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$564.11
Total Value
$205.90K
Shares Held After
49,515
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$563.01
Total Value
$74.88K
Shares Held After
49,880
% of Holdings
0.3%
LEGALZOOM.COM, INC. (LZ)
Watson Noel Bertram — Chief Operating Officer & CFO
Shares
15,000
Price
$6.45
Total Value
$96.78K
Shares Held After
2,041,847
% of Holdings
0.7%
Primerica, Inc. (PRI)
Schneider Peter W. — President
Shares
1,800
Price
$279.64
Total Value
$503.35K
Shares Held After
9,811
% of Holdings
15.5%
PubMatic, Inc. (PUBM)
Gimbel Lisa — CHIEF ACCOUNTING OFFICER
Shares
2,863
Price
$9.89
Total Value
$28.32K
Shares Held After
13,677
% of Holdings
17.3%
Ibotta, Inc. (IBTA)
Lehrman Thomas D — Director
Shares
7,763
Price
$32.11
Total Value
$249.24K
Shares Held After
32,981
% of Holdings
19.1%
HANOVER INSURANCE GROUP, INC. (THG)
Roche John C — Director
Shares
100
Price
$199.23
Total Value
$19.92K
Shares Held After
141,011
% of Holdings
0.1%
HANOVER INSURANCE GROUP, INC. (THG)
Roche John C — Director
Shares
2,516
Price
$198.65
Total Value
$499.80K
Shares Held After
141,111
% of Holdings
1.8%
Ibotta, Inc. (IBTA)
Lehrman Thomas D — Director
Shares
12,025
Price
$32.11
Total Value
$386.08K
Shares Held After
51,141
% of Holdings
19.0%
HANOVER INSURANCE GROUP, INC. (THG)
Roche John C — Director
Shares
2,260
Price
$197.61
Total Value
$446.60K
Shares Held After
143,627
% of Holdings
1.5%
HANOVER INSURANCE GROUP, INC. (THG)
Roche John C — Director
Shares
375
Price
$196.55
Total Value
$73.71K
Shares Held After
145,887
% of Holdings
0.3%
Finance of America Companies Inc. (FOA)
Prahm Jeremy — Chief Investment Officer
Shares
6,000
Price
$19.68
Total Value
$118.09K
Shares Held After
220,968
% of Holdings
2.6%
RingCentral, Inc. (RNG)
Agarwal Vaibhav — Chief Financial Officer
Shares
2,220
Price
$40.62
Total Value
$90.18K
Shares Held After
140,416
% of Holdings
1.6%
Aramark (ARMK)
Harrington Lauren A — EVP and General Counsel
Shares
9,511
Price
$53.02
Total Value
$504.28K
Shares Held After
126,854
% of Holdings
7.0%
Aramark (ARMK)
Harrington Lauren A — EVP and General Counsel
Shares
8,852
Price
$53.09
Total Value
$469.95K
Shares Held After
126,854
% of Holdings
6.5%
Duolingo, Inc. (DUOL)
Chen Stephen C. — General Counsel
Shares
700
Price
$114.22
Total Value
$79.96K
Shares Held After
52,807
% of Holdings
1.3%
Duolingo, Inc. (DUOL)
Chen Stephen C. — General Counsel
Shares
1,277
Price
$113.27
Total Value
$144.65K
Shares Held After
53,507
% of Holdings
2.3%
Duolingo, Inc. (DUOL)
Glance Natalie — Chief Engineering Officer
Shares
1,300
Price
$114.19
Total Value
$148.44K
Shares Held After
173,401
% of Holdings
0.7%
Duolingo, Inc. (DUOL)
Glance Natalie — Chief Engineering Officer
Shares
2,060
Price
$113.21
Total Value
$233.22K
Shares Held After
174,701
% of Holdings
1.2%
Sight Sciences, Inc. (SGHT)
Bauerlein Alison — Chief Operating Officer
Shares
12,728
Price
$5.12
Total Value
$65.17K
Shares Held After
688,893
% of Holdings
1.8%
ACCESS Newswire Inc. (ACCS)
Rein Graeme P. — Director
Shares
7,877
Price
$6.75
Total Value
$53.15K
Shares Held After
79,733
% of Holdings
9.9%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,108
Price
$26.76
Total Value
$29.65K
Shares Held After
227,367
% of Holdings
0.5%
STRATUS PROPERTIES INC (STRS)
JOSEPH JAMES — Director
Shares
12,335
Price
$29.08
Total Value
$358.70K
Shares Held After
3,380
% of Holdings
78.5%
Seres Therapeutics, Inc. (MCRB)
Brady Kelly — Chief Operating Officer, EVP
Shares
59
Price
$7.53
Total Value
$444.27
Shares Held After
8,562
% of Holdings
0.7%
Maplebear Inc. (CART)
Fong Morgan — Chief Legal Officer
Shares
1,458
Price
$40.39
Total Value
$58.89K
Shares Held After
544,078
% of Holdings
0.3%
Maplebear Inc. (CART)
Fong Morgan — Chief Legal Officer
Shares
12,575
Price
$39.88
Total Value
$501.52K
Shares Held After
545,536
% of Holdings
2.3%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — Chief Scientific Officer and EVP
Shares
77
Price
$7.53
Total Value
$579.81
Shares Held After
7,838
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
259
Price
$7.53
Total Value
$1.95K
Shares Held After
12,040
% of Holdings
2.1%
Showing 1051–1100 of 8678 transactions (page 22 of 174)